Perkins Coie Trust Co - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,126 filers reported holding NOVARTIS A G in Q1 2021. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.

Quarter-by-quarter ownership
Perkins Coie Trust Co ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$53,883
+313.9%
529
+310.1%
0.02%
+275.0%
Q2 2023$13,017
-80.9%
129
-82.6%
0.00%
-80.0%
Q1 2023$68,080
+481.8%
740
+473.6%
0.02%
+400.0%
Q4 2022$11,702
-74.0%
129
-78.1%
0.00%
-76.5%
Q3 2022$45,000
-19.6%
589
-11.4%
0.02%
-15.0%
Q2 2022$56,000
-39.8%
665
-37.2%
0.02%
-31.0%
Q1 2022$93,000
-45.0%
1,059
-45.1%
0.03%
-42.0%
Q4 2021$169,000
-85.6%
1,930
-86.6%
0.05%
-86.4%
Q3 2021$1,174,000
-47.2%
14,353
-41.1%
0.37%
-46.4%
Q2 2021$2,225,000
+7.9%
24,385
+1.0%
0.68%
-0.4%
Q1 2021$2,063,000
-10.6%
24,141
-1.2%
0.69%
-12.7%
Q4 2020$2,308,000
+15.7%
24,441
+6.5%
0.79%
-1.0%
Q3 2020$1,995,000
+0.5%
22,942
+1.0%
0.80%
-2.6%
Q2 2020$1,985,000
+11.0%
22,725
+4.8%
0.82%
-10.2%
Q1 2020$1,788,000
-16.8%
21,691
-4.4%
0.91%
+3.4%
Q4 2019$2,148,000
+14.9%
22,686
+5.5%
0.88%
+6.3%
Q3 2019$1,869,000
-4.4%
21,503
+0.4%
0.83%
-6.8%
Q2 2019$1,955,000
-7.1%
21,413
-2.2%
0.89%
-9.2%
Q1 2019$2,104,000
+13.9%
21,885
+1.6%
0.98%
+1.0%
Q4 2018$1,848,000
-0.3%
21,533
+0.1%
0.97%
+12.4%
Q3 2018$1,854,000
+14.0%
21,518
-0.1%
0.86%
+7.1%
Q2 2018$1,626,000
-5.4%
21,530
+1.2%
0.80%
-5.9%
Q1 2018$1,719,000
-0.7%
21,268
+3.2%
0.85%
-1.2%
Q4 2017$1,731,000
-2.0%
20,612
+0.1%
0.86%
-5.9%
Q3 2017$1,767,000
+3.6%
20,584
+0.8%
0.92%0.0%
Q2 2017$1,705,000
+12.5%
20,428
+0.1%
0.92%
+3.0%
Q1 2017$1,516,0000.0%20,414
-1.9%
0.89%
-3.2%
Q4 2016$1,516,000
-13.7%
20,819
-6.4%
0.92%
-17.4%
Q3 2016$1,756,000
-2.7%
22,245
+1.7%
1.11%
-6.4%
Q2 2016$1,804,000
+23.1%
21,864
+8.1%
1.19%
+19.4%
Q1 2016$1,465,000
-20.5%
20,224
-5.6%
1.00%
-27.9%
Q4 2015$1,843,000
-5.7%
21,426
+0.8%
1.38%
-12.1%
Q3 2015$1,954,000
-6.2%
21,256
+0.3%
1.57%
+0.1%
Q2 2015$2,083,000
-1.7%
21,186
-1.4%
1.57%
-3.7%
Q1 2015$2,119,000
+5.2%
21,489
-1.2%
1.63%
+1.5%
Q4 2014$2,015,000
-0.6%
21,751
+1.0%
1.61%
-5.7%
Q3 2014$2,028,000
+5.6%
21,544
+1.6%
1.70%
-4.9%
Q2 2014$1,920,000
+2.8%
21,211
-3.4%
1.79%
-0.6%
Q1 2014$1,868,000
+7.4%
21,966
+1.5%
1.80%
+5.3%
Q4 2013$1,740,00021,6451.71%
Other shareholders
NOVARTIS A G shareholders Q1 2021
NameSharesValueWeighting ↓
Martin Investment Management, LLC 229,184$23,344,6827.00%
Foresight Global Investors, Inc. 97,500$9,397,7375.23%
SCHARF INVESTMENTS, LLC 1,425,745$145,226,3224.34%
MANAGED ASSET PORTFOLIOS, LLC 274,204$27,930,3694.28%
GARLAND CAPITAL MANAGEMENT INC 54,710$5,572,7613.93%
PRENTISS SMITH & CO INC 52,032$5,299,9803.91%
WILKINS INVESTMENT COUNSEL INC 130,950$13,3393.61%
First Fiduciary Investment Counsel, Inc. 145,731$14,8443.48%
Cullen Capital Management, LLC 2,714,809$276,530,4643.23%
JOHN G ULLMAN & ASSOCIATES INC 182,690$18,608,8033.04%
View complete list of NOVARTIS A G shareholders